NEW ORLEANS--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, announced positive real-world data demonstrating immediate and ...
Specifically, glucose control was significantly improved within one month of Control-IQ technology use and sustained throughout a consecutive 12-month period. “This evidence suggests Control-IQ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback